Reska Biotech
GWIN · OTC
About GWIN
- Employees
- 0
- Headquarters
- Macau
- Listed
- Nov 8, 2011
- Sector
- Consumer Discretionary
- Industry
- Hotels, Restaurants & Leisure
- Website
- tophonestygroup.com
GWIN key statistics
- Market cap
- 234.77M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 200
- Volume
- 5
- Open price
- $0.6591
- High today
- $0.6591
- Low today
- $0.6591
- 52 Week high
- $3.91
- 52 Week low
- $0.1531
Reska Biotech (GWIN) at a glance
Reska Biotech (GWIN) last traded at $0.6591, with a market cap of 234.77M and a price-to-earnings ratio of 0.00.
Volume so far is 5 shares, below the average of 200 shares a day.
Over the past year Reska Biotech has ranged from $0.1531 to $3.91, and now sits 13% of the way up that range.
Similar companies
Companies in the same industry as Reska Biotech
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- RBNERobin Energy$0.3978−23.65%
- SDSTStardust Power$0.02−23.66%
- RCTRedCloud Holdings$0.084+1.94%
- WFFWF Holding$0.0929−3.83%
- NIVFNewGenIvf Group$0.2499−11.73%
- NWGLCL Workshop Group$0.1522+27.90%
- AHTAshford Hospitality Trust$1.79−2.72%
- DKIDarkiris$0.0479−6.08%
- KORUDirexion Shares ETF Trust$11.34−4.87%
- SPCXSpace Exploration Technologies$147.79−0.11%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.